Acelrx Pharmaceuticals Inc

NASDAQ:ACRX   12:50:30 AM EDT
2.43
+0.08 (+3.40%)
Earnings Announcements

AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results, Provides Corporate Update

Published: 11/14/2022 21:53 GMT
Acelrx Pharmaceuticals Inc (ACRX) - Acelrx Pharmaceuticals Inc Q3 Sales Rose 217 Percent to $500,000.
Acelrx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Acelrx Pharmaceuticals Inc - $20.9 Million in Cash and Short-term Investments As of September 30, 2022.
Acelrx Pharmaceuticals Inc - Qtrly Loss per Share $0.94.
Revenue is expected to be $4.5 Million
Adjusted EPS is expected to be -$10.20

Next Quarter Revenue Guidance is expected to be $0.6 Million
Next Quarter EPS Guidance is expected to be -$1.39

More details on our Analysts Page.